GBLP Stock Overview
Global Pharmatech, Inc. engages in the research, production, and development of herbal medicine, bio-medicine, chemical medicine, traditional chinese medicine, and dietary supplements primarily in China.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Global Pharmatech, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.15 |
| 52 Week High | US$0.25 |
| 52 Week Low | US$0.11 |
| Beta | 0 |
| 1 Month Change | 0% |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 3 Year Change | 15.38% |
| 5 Year Change | -70.59% |
| Change since IPO | -99.95% |
Recent News & Updates
No updates
Recent updates
No updates
Shareholder Returns
| GBLP | US Personal Products | US Market | |
|---|---|---|---|
| 7D | 0% | -4.5% | 0.7% |
| 1Y | n/a | -24.9% | 23.9% |
Return vs Industry: Insufficient data to determine how GBLP performed against the US Personal Products industry.
Return vs Market: Insufficient data to determine how GBLP performed against the US Market.
Price Volatility
| GBLP volatility | |
|---|---|
| GBLP Average Weekly Movement | n/a |
| Personal Products Industry Average Movement | 8.6% |
| Market Average Movement | 6.1% |
| 10% most volatile stocks in US Market | 16.6% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: GBLP has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine GBLP's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2001 | n/a | Lian Qu | n/a |
Global Pharmatech, Inc. engages in the research, production, and development of herbal medicine, bio-medicine, chemical medicine, traditional chinese medicine, and dietary supplements primarily in China. The company’s principal product line consists of XS CAPSULE (XIN-SHU) for the treatment of angina and other coronary disease; JUTAI SOFT CAPSULE, a dietary supplement; QINGXUAN ANTI-HYPERTENSION TABLET, an over-the-counter drug product indicated for the treatment of hypertension and high serum cholesterol level; and YANREQING TABLET for the treatment of inflammation. It also manufactures and sells other proprietary drugs, generics, and dietary supplements used to treat symptoms ranging from headaches, coughing, and dry mouth to infections, and numbness of limbs.
Global Pharmatech, Inc. Fundamentals Summary
| GBLP fundamental statistics | |
|---|---|
| Market cap | US$59.28m |
| Earnings (TTM) | -US$2.24m |
| Revenue (TTM) | US$3.18m |
0.0x
P/S Ratio0.0x
P/E RatioIs GBLP overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| GBLP income statement (TTM) | |
|---|---|
| Revenue | US$3.18m |
| Cost of Revenue | US$1.71m |
| Gross Profit | US$1.47m |
| Other Expenses | US$3.71m |
| Earnings | -US$2.24m |
Last Reported Earnings
Jun 30, 2008
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did GBLP perform over the long term?
See historical performance and comparison